Sign In
Buy ALT
$2.87
-0.0300 (-1.03%)
At Close: Jun 03, 2026
Why Altimmune's Stock Is Trading Higher Today
03:30pm, Thursday, 09'th Jul 2020
Altimmune (NASDAQ: ALT) shares are trading higher on Thursday after the company signed a teaming agreement with DynPort vaccine company on U.S. government funding efforts for its AdCOVID vaccine candi
GAITHERSBURG, Md., July 09, 2020 -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it has entered into a teaming agreement with.
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
12:00am, Thursday, 09'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 8)
Akero Therapeutics Inc (...
What Type Of Shareholders Make Up Altimmune, Inc.'s (NASDAQ:ALT) Share Registry?
12:04pm, Wednesday, 08'th Jul 2020
If you want to know who really controls Altimmune, Inc. (NASDAQ:ALT), then you'll have to look at the makeup of its...
6 Stocks That Could Pop Higher
12:00am, Wednesday, 08'th Jul 2020
Stocks Analysis by Harry Boxer covering: BioCryst Pharmaceuticals Inc, Cytokinetics Inc, Vaxart Inc, Novavax Inc. Read Harry Boxer's latest article on Investing.com
Global Biodefense Market (2020 to 2030) - by Product, Sales Channel, Application, and Region - ResearchAndMarkets.com
12:00am, Monday, 06'th Jul 2020
The
Leaf Group, Forma Therapeutics See Activist Action
11:30pm, Thursday, 02'nd Jul 2020
Oak Investment Partners disclosed a large stake in digital-content provider Leaf Group. Forma Therapeutics said it owns more than nine million shares of biopharmaceutical firm Forma.
'Disaster' as 350 elephants mysteriously drop dead near waterholes in Africa
01:13pm, Thursday, 02'nd Jul 2020
AT LEAST 350 elephants have mysteriously dropped dead near waterholes in Africa… and nobody knows why it’s happened. The gentle giants reportedly died from unknown causes and aerial sho…
Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, today announced dosing of the first patient in the Company’s Phase 1b clinical trial of NasoShield, a single dose intranasal anthra
Coronavirus Vaccine Update, June 29
09:59am, Tuesday, 30'th Jun 2020
Genetic vaccines take DNA or RNA coding for coronavirus proteins and inject that directly into the bloodstream. Novavax has been raising significant amounts of
The following is a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 29)
ADC Therapeutics SA (...
Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, today announced it was awarded $4.7 million from the U.S. Army Medical Research & Development Command (USAMRDC) to fund its Phase 1/2
The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts
12:00am, Friday, 26'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 25)
Brainstorm Cell...
iShares Diversified Alternatives Trust (NYSEARCA:ALT) Rating Lowered to Sell at Zacks Investment Research
01:54am, Wednesday, 24'th Jun 2020
iShares Diversified Alternatives Trust (NYSEARCA:ALT) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Monday, Zacks.com reports
